Peak Financial Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Peak Financial Management's LLY Position: Q3 2026 in Review
Peak Financial Management increased its Eli Lilly (LLY) stake by 9.4% in Q3 2026, buying an estimated $35.4K and bringing the position to 350 shares worth $405K. The position accounts for 0.09% of the portfolio, ranked #68.
Peak Financial Management first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $508K in Q1 2024. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Peak Financial Management held 350 shares of Eli Lilly worth $405K as of Q3 2026.
- Peak Financial Management bought 30 Eli Lilly shares in Q3 2026, an estimated $35.4K.
- Eli Lilly made up 0.09% of Peak Financial Management's portfolio in Q3 2026, its #68 holding.
- Peak Financial Management first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
- Peak Financial Management's Eli Lilly position peaked at $508K in Q1 2024.
- 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Peak Financial Management's 13F filing for Q3 2026, filed 16 Oct 2026.